ATHE Alterity Therapeutics Limited

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2025

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1

Notice Under Section 708A & Application for quotation of securities

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Alterity Therapeutics Limited
	By:	/s/ Geoffrey P. Kempler
		Geoffrey P. Kempler
		Chairman

 

Date: February 4, 2025

 

 

2

Exhibit 99.1

 

 

ASX ANNOUNCEMENT

04 February 2025

 

Notice Under Section 708A(5)(e) of the Corporations Act

 

This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).

 

Details of securities issued
Type:		Shares
Class/Description:		Fully paid ordinary shares
ASX Code:		ATH
Date of Issue:		03 February 2025
Number Issued:		164,242,200

 

The Company gives notice pursuant to section 708A(5)(e) of the Corporations Act that:

 

1.

the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act;

 

2.

as at the date of this notice, the Company has complied with:

 

(i)

the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

 

(ii)

sections 674 and 674A of the Corporations Act; and

 

3.

as at the date of this notice there is no information to be disclosed which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.

 

/s/ Abby Macnish Niven
Abby Macnish Niven
Company Secretary

 

 

Alterity Therapeutics Limited ACN 080 699 065

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

www.alteritytherapeutics.com

 

 

Appendix 2A - Application for quotation of securities

 

Announcement Summary

 

 

Entity name

 

ALTERITY THERAPEUTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Tuesday February 04, 2025

 

The +securities to be quoted are:

 

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Total number of +securities to be quoted

 

	ASX +security code	Security description	Number of +securities to be quoted	Issue date
	ATH	ORDINARY FULLY PAID	164,242,200	03/02/2025

Refer to next page for full details of the announcement

 

 

Appendix 2A - Application for quotation of securities

 

Part 1 - Entity and announcement details

 

 

1.1 Name of entity

 

ALTERITY THERAPEUTICS LIMITED

 

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

 

	1.2 Registered number type	Registration number
	ABN	37080699065

 

1.3 ASX issuer code

 

ATH

 

1.4 The announcement is

 

New announcement

 

1.5 Date of this announcement

 

4/2/2025

 

 

Appendix 2A - Application for quotation of securities

 

Part 2 - Type of Issue

 

 

2.1 The +securities to be quoted are:

 

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Previous Appendix 3B details:

 

Announcement Date and Time	Announcement Title	Selected Appendix 3B to submit quotation request
03-Feb-2025 09:58	New - Proposed issue of securities - ATH	A placement or other type of issue

 

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

 

No

 

 

Appendix 2A - Application for quotation of securities

 

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

 

 

Placement Details

 

 

ASX +security code and description

 

ATH : ORDINARY FULLY PAID

 

Issue date

 

3/2/2025 

 

Distribution Schedule

 

 

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category. 

 

		Total percentage of +securities held
Number of +securities held	Number of holders	For example, to enter a value of 50% please input as 50.00
1 - 1,000		%
1,001 - 5,000		%
5,001 - 10,000		%
10,001 - 100,000		%
100,001 and over		%

 

 

Appendix 2A - Application for quotation of securities

 

Issue details

 

 

Number of +securities to be quoted

 

164,242,200

 

Are the +securities being issued for a cash consideration?

 

Yes

 

	In what currency is the cash consideration being paid?	What is the issue price per +security?
	AUD - Australian Dollar	AUD 0.01290000

 

Any other information the entity wishes to provide about the +securities to be quoted

 

 

 

Appendix 2A - Application for quotation of securities

 

Part 4 - Issued capital following quotation

 

 

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

 

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

 

ASX +security code and description		Total number of +securities on issue
ATH : ORDINARY FULLY PAID			5,491,006,889
ATHO : OPTION EXPIRING 31-AUG-2026			932,611,430

 

4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)

 

ASX +security code and description		Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375			14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238			11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09			35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01			170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105			8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031			62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004			20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003			120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032			91,392,720

 

---